serum ykl 40 levels (Boster Bio)
Structured Review
Serum Ykl 40 Levels, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/serum+ykl+40+levels/Human+recombinant+CHI3L1+(Chitinase-3-like+protein+1)+protein%2C+AF/pm37741051-117-0-15
Average 93 stars, based on 12 article reviews
Images
Related Articles
other:Article Title: Serum YKL-40 predicts long-term outcome in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction Article Snippet: Serum Article Title: Elevated YKL-40 serum levels in patients with chronic spontaneous urticaria. Article Snippet: Serum YKL-40 levels in all groups were measured by 42 Human Chitinase 3-like 1/YKL-40 ELISA Kit (Boster Biological Technology, 43 Wuhan, China. Enzyme-linked Immunosorbent Assay:Article Title: N-Acetyl cysteine amide and cerium oxide nanoparticles as a drug delivery for ischemic stroke treatment: Inflammation and oxidative stress crosstalk. Article Snippet: Background: Inflammation and oxidative stress crosstalk is involved in the ischemic stroke(IS) pathogenesis and the new therapeutic options should be offered based on the targets that are critical in the golden hour of IS.. YKL40 and total antioxidant capacity(TAC), the inflammation and oxidative stress biomarkers, provide us with clues for proper intervention targets.. N-acetyl cysteine amide (NACA), a lipophilic antioxidant, with a nanoparticlebased drug delivery system is permeable enough to penetrate blood-brain barrier (BBB) and was proposed as a new treatment option for IS. |

![Upregulation of <t>CHI3L1</t> correlates with distant metastasis and poor prognosis of human GCs. a Western blot analysis of <t>CHI3L1</t> <t>protein</t> expression in 5 pairs of gastric tissues (GC and adjacent non-cancerous tissues) after curative resection. Data represent mean ± SEM; * p < 0.05 (Student’s t test). b Immunohistochemical analysis of CHI3L1 protein levels in GC samples on tissue microarrays. Representative examples of CHI3L1 expression in adjacent non-cancerous gastric tissues, GC tissues and GC metastases tissues (lymph node and pancreas) are shown. Scale bars represent 100 μm. c - e Serum CHI3L1 levels in GC patients ( n = 100) and normal controls ( n = 50) ( c ); Serum CHI3L1 levels in GC patients with different tumor invasive depth ( d ) ( n = 17 [T1 + T2], n = 83 [T3 + T4]) and lymph node metastasis ( e ) ( n = 21 [N0 + N1], n = 79 [N1 + N2]). Mann-Whitney U test was used to assess p values; * p < 0.05. f - i The overall survival of patients with high or low CHI3L1 expression in GC tissues. Kaplan-Meier test was used to analyze p values](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_7920/pmc06117920/pmc06117920__13046_2018_876_Fig1_HTML.jpg)

